Home Search
cybn - search results
If you're not happy with the results, please do another search
Cybin (CYBN) Announces Unprecedented Positive Phase 2 Data After Single Dose.
Conference call to discuss CYB003 interim results today, November 1, 2023 at 11:00 a.m. ET
Adding Cybin (CYBN) $0.46 to 2024 Top Psychedelic Stocks Watch List.
Steve Cohen from Point 72, Acquires 18,950,000 Shares of Cybin.
Cybin (CYBN) and Kernel Announce Results from Kernel Flow® Piloting of Feasibility Study Measuring Ketamine’s...
- Preliminary data confirm Flow's ability to successfully measure neuro-effect of ketamine over 10 days -
- Results to...
Cybin (CYBN) Announces FDA Investigational New Drug Authorization of Cybin’s Sponsored Feasibility Study Using...
October 26, 2021 07:30 AM Eastern Daylight Time
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biotechnology...
Cybin (CLXPF CYBN) Banks $30 Million Overnight.
Cybin Announces Size and Pricing of Previously Announced Overnight Marketed Public Offering of Common Shares.
LIVE QUOTE
Cybin (CLXPF CYBN) Gets $8.00 Price Target From H.C. Wainwright.
Advancing Multiple Psychedelics in Multiple Indications; Initiating With a Buy and $8 Price Target.
Wonderland Miami: Public Companies.
Plenty of public companies making an appearance. Way outnumbered by the experts and 'thought-leaders' from the medical community - but we can...
Psychedelic Investor Conferences.
Not Quite as Popular as the Bitcoin 2021 Conference Attended by 12,000 - But Worth Considering!
Greenbrook Health Centers (GBNH) Changing the Way Depression is Treated.
Cybin Enters into Collaboration Agreement with Greenbrook TMS to Establish Mental Health Centers of Excellence
https://youtu.be/yrr-wlFftT0